Madison, CT, United States of America

Michael Girardi

This inventor holds 9 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Yale University, Transimmune Ag, Other. Active years: 1986-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Girardi. Retrieved from https://idiyas.com/inventor/michael-girardi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 88.9


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Wallington, NJ (US) (1986 - 1988)
  • Madison, CT (US) (2006 - 2024)

Company Filing History:

goldMedal7 out of 1,370 
 
Yale University
 patents
silverMedal2 out of 2 
 
Transimmune Ag
 patents
bronzeMedal1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1986-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: **Michael Girardi: Innovator in Dermatological Applications**

Introduction

Michael Girardi, an inventor based in Madison, CT, has made significant contributions to the field of dermatology through his innovative research and patent portfolio. With a total of six patents to his name, he has developed cutting-edge formulations aimed at preventing skin cancer and improving skin health.

Latest Patents

Among Michael's latest patents is the groundbreaking work titled "Dermatologic topical applications of ROR gamma and ROR gamma-t inhibitors for the prevention of skin cancer development." This patent describes methods and compositions designed to reduce or inhibit skin cancer development in individuals in need.

Another key patent includes the "Topical formulation of hyperbranched polymer-coated particles." This innovation involves core-shell particles where the hydrophobic core is coated with hyperbranched polymers. These coatings can be modified to adjust the particles' properties, enabling them to resist non-specific protein absorption and facilitate adhesion to tissues, cells, or extracellular materials. The particles created in this formulation potentially incorporate cosmetic, therapeutic, diagnostic, nutraceutical, and prophylactic agents, including sunblock compositions.

Career Highlights

Michael has collaborated with notable institutions throughout his career. He has worked with Yale University, where his research efforts have contributed to significant advancements in dermatological science. Additionally, he has been associated with Transimmune AG, further enhancing his expertise in the field.

Collaborations

Throughout his career, Michael has had the opportunity to work alongside other talented researchers, including Richard L Edelson and Carole L Berger. These collaborations have fostered an environment of innovation, leading to the development of transformative cosmetic and therapeutic applications.

Conclusion

Michael Girardi's work exemplifies the spirit of innovation in the field of dermatology. With a focus on creating effective preventative measures against skin cancer and enhancing skin formulations, his contributions continue to impact the industry positively. As advancements in this field evolve, Michael's inventions will likely pave the way for future developments in skin health and safety.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…